赛伦生物
(688163)
| 流通市值：26.36亿 | | | 总市值：26.36亿 |
| 流通股本：1.08亿 | | | 总股本：1.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 74,948,031.35 | 133,341,233.87 | 350,924,252.18 | 182,107,137.22 |
| 交易性金融资产 | 711,297,780.82 | 611,868,602.74 | 449,001,068.49 | 641,207,523.29 |
| 应收票据及应收账款 | 77,806,092.94 | 98,582,846.11 | 50,218,685.97 | 36,678,957.69 |
| 其中：应收票据 | 12,626,216.34 | - | 1,015,200 | - |
| 应收账款 | 65,179,876.6 | 98,582,846.11 | 49,203,485.97 | 36,678,957.69 |
| 预付款项 | 1,027,208.02 | 128,500 | 1,917,505 | 488,112 |
| 其他应收款合计 | 1,070,170.45 | 978,192.93 | 909,956.45 | 794,640.4 |
| 存货 | 38,759,460 | 42,405,191.16 | 47,473,661.57 | 43,275,462.94 |
| 其他流动资产 | 12,601,247.24 | 20,597,899.56 | 11,817,428.19 | 11,811,112.16 |
| 流动资产合计 | 917,509,990.82 | 907,902,466.37 | 912,262,557.85 | 916,362,945.7 |
| 非流动资产: | | | | |
| 固定资产 | 114,577,515.78 | 104,488,670.43 | 106,482,025.18 | 108,979,777.03 |
| 在建工程 | 70,180,938.94 | 63,653,512.88 | 47,439,075.69 | 41,840,485.62 |
| 生产性生物资产 | 3,708,003.57 | 2,996,024.52 | 3,122,436.95 | 2,891,422.12 |
| 使用权资产 | 3,395,117.2 | 3,474,073.39 | 3,553,029.58 | 3,631,985.77 |
| 无形资产 | 22,667,428.04 | 22,862,317.28 | 22,842,706.52 | 23,032,095.77 |
| 长期待摊费用 | 454,690.89 | 514,677.63 | 574,664.37 | 634,651.11 |
| 递延所得税资产 | 8,065,850.1 | 8,541,275.49 | 8,017,978.31 | 7,998,184.1 |
| 其他非流动资产 | 20,974,500 | 21,094,954.85 | 11,722,500 | 14,662,409.7 |
| 非流动资产合计 | 244,024,044.52 | 227,625,506.47 | 203,754,416.6 | 203,671,011.22 |
| 资产总计 | 1,161,534,035.34 | 1,135,527,972.84 | 1,116,016,974.45 | 1,120,033,956.92 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 10,879,814.14 | 1,888,452.95 | 2,520,597.86 | 1,311,620.5 |
| 应付账款 | 10,879,814.14 | 1,888,452.95 | 2,520,597.86 | 1,311,620.5 |
| 合同负债 | 2,915,190.56 | 3,729,443.79 | 1,967,380.8 | 2,204,866.2 |
| 应付职工薪酬 | 6,402,637.65 | 4,873,189.22 | 1,733,231.28 | 8,138,301.13 |
| 应交税费 | 7,166,256.22 | 7,911,037.06 | 1,954,014.62 | 1,114,122.04 |
| 其他应付款合计 | 4,190,476.66 | 5,116,942.53 | 3,641,263.58 | 6,493,691.05 |
| 应付股利 | 22,900 | 21,700 | 19,700 | 19,700 |
| 一年内到期的非流动负债 | 309,157.83 | 309,157.83 | 296,316.87 | 293,447.16 |
| 其他流动负债 | 87,455.71 | 155,744.64 | 59,021.42 | 66,146 |
| 流动负债合计 | 31,950,988.77 | 23,983,968.02 | 12,171,826.43 | 19,622,194.08 |
| 非流动负债: | | | | |
| 租赁负债 | 3,653,402.71 | 3,842,144.35 | 4,042,306 | 4,003,157.65 |
| 递延所得税负债 | 848,780.3 | 868,518.35 | 907,996.44 | 907,996.44 |
| 非流动负债合计 | 4,502,183.01 | 4,710,662.7 | 4,950,302.44 | 4,911,154.09 |
| 负债合计 | 36,453,171.78 | 28,694,630.72 | 17,122,128.87 | 24,533,348.17 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 |
| 盈余公积 | 51,677,171.45 | 51,677,171.45 | 51,677,171.45 | 51,677,171.45 |
| 未分配利润 | 87,095,877.25 | 68,848,355.81 | 60,909,859.27 | 57,515,622.44 |
| 归属于母公司股东权益合计 | 1,125,080,863.56 | 1,106,833,342.12 | 1,098,894,845.58 | 1,095,500,608.75 |
| 股东权益合计 | 1,125,080,863.56 | 1,106,833,342.12 | 1,098,894,845.58 | 1,095,500,608.75 |
| 负债和股东权益合计 | 1,161,534,035.34 | 1,135,527,972.84 | 1,116,016,974.45 | 1,120,033,956.92 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |